New Drug discovery in Hematology

Currently pharmaceutical firms are involved in the main specializing in Recombinant, genetically engineered pharmaceuticals which may be smart alternative for treatment. If you have got a gentle form of hemophilia, a medicine referred to as desmopressin acetate (DDAVP) will briefly increase the concentration of factor VIII in your blood. DDAVP may be given intravenously, through an injection, or within the type of nasal spray. Antifibrinolytic medicines like tranexamic acid and epsilon aminocaproic acid are that are typically used with replacement therapy to assist keep blood clots from breaking down.

  • Clinical trials
  • Drug Repurposing
  • Patient-reported outcomes in drug development
  • Hematopoietic cells Mobilization

Related Conference of New Drug discovery in Hematology

February 24-25, 2025

4th European Congress on Hematology

Madrid, Spain
July 07-08, 2025

23rd World Hematology Congress

Zurich, Switzerland

New Drug discovery in Hematology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in